Nissim Mashiach, President and COO at Omrix Biopharmaceuticals, Inc. (OMRI), bought 2,000 shares at $14.50 ($29K) on 2008-03-31, disclosed to the SEC on 2008-04-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |